Peptide Therapy

Peptide therapy in New Jersey utilizes peptides, short chains of amino acids, to address various health conditions. Peptides naturally occur in the body and are essential in regulating many physiological processes, such as metabolism, immune function, and hormone production. Peptide therapy involves administering synthetic peptides to supplement or mimic the actions of natural peptides in the body, treating a range of conditions, including obesity, diabetes, autoimmune disorders, and age-related diseases such as osteoporosis and cognitive decline. Progressive Wellness offers the following:

Tesofensine

Tesofensine is a peptide therapy that has shown potential in treating obesity and related disorders. It works by inhibiting the reuptake of dopamine, norepinephrine, and serotonin, leading to increased energy expenditure and decreased appetite.

Phentermine

Phentermine is a peptide therapy used in the treatment of obesity. It suppresses appetite and increases energy expenditure by releasing norepinephrine in the brain. While effective in the short term, long-term use can lead to tolerance and potential side effects such as increased blood pressure and heart rate.

Rybelsus

Rybelsus is a peptide therapy used in the treatment of type 2 diabetes. It works by mimicking the effects of the hormone GLP-1, which regulates blood sugar levels and appetite. Unlike other GLP-1 agonists, Rybelsus is taken orally and has been shown to improve glycemic control and reduce cardiovascular risk effectively.

Liragludite (Victoza)

Liraglutide, or Victoza, is a peptide therapy for treating type 2 diabetes and obesity. It mirrors the effects of the hormone GLP-1 to balance blood sugar levels and appetite. It has been shown to improve glycemic control, reduce weight, and lower cardiovascular risk.

Tirzepatide

Tirzepatide is a peptide therapy currently in clinical trials for treating type 2 diabetes and obesity. It works by activating the GLP-1 and GIP receptors, improving blood sugar control and weight loss. Early studies have shown promising results with fewer side effects than other GLP-1 agonists.

Phendimetrazine (Bontril)

Phendimetrazine, also known as Bontril, is a prescription weight loss medication. It suppresses appetite and increases metabolism by releasing norepinephrine in the brain. It is typically used as a short-term treatment for obesity and is often prescribed with diet and exercise.

Contrave

Contrave is a peptide therapy used in the treatment of obesity. It combines bupropion and naltrexone to suppress appetite and reduce cravings for food and alcohol. It has been shown to promote weight loss and improve cardiovascular health effectively but may cause side effects such as nausea and headaches.

Benzphetamine (Didrex)

Didrex, or Benzphetamine, is a prescription drug used for weight loss. By stimulating the release of norepinephrine in the brain, it reduces appetite and boosts metabolism. It is commonly prescribed as a short-term solution for obesity and is typically accompanied by a healthy diet and exercise regimen.

GW-501516

GW-501516, also known as Cardarine, is a peptide therapy studied for its potential in improving endurance and fat burning. It works by activating the PPAR-delta pathway, which increases the expression of genes involved in energy metabolism.

MK-2866

MK-2866, also known as Ostarine, is a peptide therapy in New Jersey studied for its potential in treating muscle wasting and osteoporosis. It works by selectively targeting androgen receptors in the body, increasing muscle mass and bone density.

Background media

Semorelin

Semorelin is a peptide therapy for treating growth hormone deficiency in children and adults. It stimulates the pituitary gland to produce and release more growth hormones, increasing muscle mass, bone density, and overall growth. It is typically administered via injection and is safe and effective in clinical trials.

LGD -4033

Ligandrol, or LGD-4033, is a peptide therapy that has been researched for its potential in treating muscle wasting and osteoporosis. This compound selectively targets androgen receptors in the body, which can increase muscle mass and bone density.

BPC-157

BPC-157 is a peptide therapy that has been studied for its potential to promote healing and reduce inflammation. It works by stimulating the production of growth factors and promoting the formation of new blood vessels. It effectively treats various injuries, such as tendon and ligament damage, and has a good safety profile.

It's time you started Living

Contact us media

It's time you started Feeling

Contact us media

It's time you started Loving

Contact us media

It's time you started Life

Contact us media

Start your journey today.

Contact Us
Accessibility: If you are vision-impaired or have some other impairment covered by the Americans with Disabilities Act or a similar law, and you wish to discuss potential accommodations related to using this website, please contact our Accessibility Manager at 732-307-3110.
Contact Us